Together, these findings indicated that the up‐regulation of ISG15 in mice increases their susceptibility to renal tubular dysfunction and DKD development under diabetic conditions, suggesting that ISG15 may as a potential therapeutic target in DKD management. This evidence concerns the gene ISG15 and diabetic kidney disease.